UniversityLibraryCurrent studentsStaff intranet
University of Sydney
University of Sydney
View Item 
  • Sydney eScholarship Home
  • Postgraduate Theses
  • Sydney Digital Theses (Open Access)
  • View Item
  • Sydney eScholarship Home
  • Postgraduate Theses
  • Sydney Digital Theses (Open Access)
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Platelet and erythrocyte functional defects caused by mutations of GFI1B

Thumbnail
View/Open
Thesis (PDF, 8.39MB)
Date
2018-12-31
Author
Beutler, Lucinda
Metadata
Show full item record
Abstract
GFI1B is a transcriptional repressor that is a major regulator of megakaryocytic and erythroid differentiation and development. The cause of a bleeding disorder in a four- generation Australian family, with cell changes consistent with aberrant platelet structure and function, and red blood cell morphology, showing autosomal dominant inheritance, was identified as being caused by a single nucleotide insertion into the GFI1B gene (c.880_881insC). The aims of this thesis were to study the effects of this mutant GFI1B on erythrocyte development in a cell culture model; to study how loss of Gfi1b function affects megakaryocytic development in a conditional knockout mouse model; and to examine the effects of human GFI1Bc.880_881insC on megakaryocytic / erythroid cell development in a transgenic mouse model, with correlation to the human phenotype. Separate lines of erythroleukaemic K562 cells were transfected with GFI1BWT and GFI1Bc.880_881insC for studies into red cell formation. Inconclusive results from constant loss of transfection led to the view that a cell model derived from iPSC from affected family members would provide a more stable system for this study. For the conditional knockout mouse model, C57BL/6J mice with floxed Gfi1b alleles were cross-bred to transgenic mice expressing Cre recombinase under the platelet factor 4 (Pf4) promoter to create a null allele. Mice with retained floxed alleles were controls. The effects of the loss of ­Gfi1b along the megakaryocytic lineage included 60-fold reduction in platelet count; aberrant megakaryocyte morphology, with high DNA ploidy and increased numbers in bone marrow and spleen; high plasma TPO level; enlarged spleens with evidence of stress erythropoiesis; and reduced red cell indices. Reported studies in the literature corroborated these findings. C57BL/6J transgenic mice with either GFI1BWT or GFI1Bc.880_881insC with a lox-STOP-lox cassette inserted at the collagen Col1a1 locus were crossed with transgenic mice expressing Pf4-Cre for the transgenic mouse model. The premise, that the human mutant GFI1B would cause a dominant negative effect on the endogenous mouse Gfi1b, was not seen in the lack of a bleeding phenotype, and evidence of normal haematological parameters in these mice. A knock-in model with GFI1Bc.880_881insC replacing Gfi1b may be more effective.
URI
http://hdl.handle.net/2123/20481
Collections
  • Sydney Digital Theses (Open Access) [4724]

Browse

All of Sydney eScholarshipCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

My Account

LoginRegister

Statistics

Most Popular ItemsStatistics by CountryMost Popular Authors

Links

University homeLibraryCurrent studentsStaff intranet

Repository

  • About us
  • FAQ
  • Policies & guidelines
  • Email us
  • Non-UniKey login
Leadership for good starts here

Media

  • News
  • Find an expert
  • Media contacts

Student links

  • Log in to University systems
  • Study dates
  • Student handbooks
  • Timetables
  • Library

About us

  • Our world rankings
  • Faculties and schools
  • Centres and institutes
  • Campus locations
  • Maps and locations

Connect

  • Contact us
  • Find a staff member
  • Careers at Sydney
  • Events
  • Emergencies and personal safety
Inspired: Campaign to support the University of SydneyGroup of Eight
Disclaimer
Privacy
Accessibility
Website feedback
ABN: 15 211 513 464
CRICOS Number: 00026A
Disclaimer
Privacy
Accessibility
Website feedback
ABN: 15 211 513 464
CRICOS Number: 00026A